Disruption of Na
It has long been speculated that disturbed intracellular pH (pH i ) regulation could be important for development of artery dysfunction and cardiovascular disease. The lack of experimental techniques allowing for selective changes in pH i without affecting extracellular conditions has, however, precluded direct studies into the effects of pH i disturbances in the artery wall. In the present study, we used a functional genetics approach to abolish expression of the Na ϩ ,HCO 3 cotransporter NBCn1, which is responsible for pH i control in both vascular smooth muscle and endothelial cells. The cardiovascular function was greatly disturbed by the low intracellular pH resulting from lack of NBCn1 expression. Our findings for the first time directly demonstrate the potential of pH i disturbances in the artery wall and add to the existing complexity of signaling pathways involved in control of artery contractile function and blood pressure. NBCn1 knockout mice were mildly hypertensive at rest but protected against angiotensin-II-induced hypertension. The molecular basis for the altered artery function originated from reduced endothelial NO production and inhibited rho-kinase signaling. Hence, disturbed pH i in the artery wall affects key signaling pathways and may prove particularly important for development of artery dysfunction during conditions of local ischemia or possibly in patients with genetic mutations in NBCn1. These new mechanisms implicated in blood pressure regulation and cardiovascular control provide a potential new target to consider in the treatment of artery dysfunction and blood pressure disturbances. See p 1819.
Cardiac Magnetic Resonance Imaging Pericardial Late Gadolinium Enhancement and Elevated Inflammatory Markers Can Predict the Reversibility of Constrictive Pericarditis After Antiinflammatory Medical Therapy: A Pilot Study
Constrictive pericarditis (CP) is a disabling disease and usually requires pericardiectomy to relieve heart failure symptoms. Reversible cases of CP after antiinflammatory therapy have been described, but there is no known method to predict the reversibility. We report our pilot study to assess whether cardiac magnetic resonance imaging (CMR) pericardial late gadolinium enhancement (LGE) can predict the reversibility of CP after a course of antiinflammatory therapy. Twenty-nine patients received antiinflammatory medications after CMR. Fourteen patients had resolution of CP, whereas 15 had persistent constrictive physiology. Baseline LGE pericardial thickness was greater in the reversible CP group than in the persistent CP group. Qualitatively rated severity of pericardial LGE was moderate or severe in 93% of the reversible CP group versus 33% of the persistent CP group. CMR LGE pericardial thickness Ն3 mm had 86% sensitivity and 80% specificity to predict reversibility. The reversible CP group also had a higher baseline C-reactive protein and erythrocyte sedimentation rate level than the persistent CP group. Antiinflammatory therapy was associated with a reduction in pericardial LGE, C-reactive protein, and erythrocyte sedimentation rate in the reversible CP group but not in the persistent CP group. Our findings in this pilot observation suggest that reversible CP is associated with pericardial and systemic inflammation. Furthermore, antiinflammatory therapy is associated with a reduction of pericardial and systemic inflammation, as well as pericardial thickness on CMR LGE imaging, with resolution of constrictive physiology and symptoms. Antiinflammatory therapy should be considered in CP patients with these features before pericardiectomy. Our findings need to be validated by further studies in a larger number of patients. See p 1830.
Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy
Clinically, vitamin D has usually been linked to disorders of the skeletal system where vitamin D deficiency is associated with an increase in fracture risk. More recently, it has become clear that vitamin D has important actions in nonclassic target tissues like the immune system, heart, and vasculature. This study provides the first demonstration for a direct effect of the liganded vitamin D receptor (VDR) in the heart. Using a specially engineered mouse model, we have produced selective deletion of the VDR in the cardiac myocyte. This deletion leads to an increase in heart weight-to-body weight ratio, an increase in myocyte size without interstitial fibrosis, and activation of a gene expression program that is typically associated with hypertrophy and fibrosis. Of note, deletion of the VDR leads to activation of a signaling molecule called the modulatory calcineurin inhibitory protein 1 (MCIP1) that is known to play a role in the prohypertrophic, calcineurin-dependent signaling cascade. Treatment of myocytes in culture with a potent vitamin D metabolite leads to a reduction in MCIP1 gene expression. These findings present the first definitive support for a direct beneficial effect of vitamin D and its metabolites in the heart. They imply that vitamin D sufficiency, acquired through diet or ultraviolet light, is important for cardiovascular health and suggest that more potent vitamin D analogues may 
Urokinase-Type Plasminogen Activator Promotes Paracellular Transmigration of Neutrophils Via Mac-1, But Independently of Urokinase-Type Plasminogen Activator Receptor
Ischemia-reperfusion is still the most common cause for organ dysfunction and failure after myocardial infarction, hemorrhagic shock, and transplantation. Neutrophil recruitment to the reperfused tissue as well as postischemic microvascular leakage are critical for the pathogenesis of ischemia-reperfusion injury. Although plasminogen activators such as recombinant urokinase-type plasminogen activator (uPA) are used therapeutically for the activation of the fibrinolytic system in thrombembolic events, endogenously produced uPA has recently been implicated in the progression of ischemia-reperfusion injury. The underlying mechanisms remain poorly understood. In the present study, we found that endogenous uPA promotes intravascular accumulation and paracellular transmigration of neutrophils to the reperfused tissue independently of the uPA receptor via the integrin CD11b/Mac-1, which serves as an alternative receptor of uPA. Endothelial-presented uPA is thought to promote leukocyte intravascular adherence via its nonproteolytic properties whereas leukocyte uPA is thought to trigger the subsequent paracellular transmigration of neutrophils. We further show that postischemic microvascular leakage is mediated by uPA in a uPA receptor-dependent manner. Pharmacological inhibition of uPA interferes with these inflammatory events and attenuates postischemic neutrophil responses, microvascular leakage, and tissue injury. Because fibrinolysis is known to be largely dependent on the plasminogen-activating action of endogenous tissue-plasminogen activator and clinical trials did not provide any evidence of prothrombotic side effects relative to uPA inhibitors, pharmacological blockade of endogenously released uPA might emerge as a feasible strategy for the prevention of ischemia-reperfusion injury. See p 1848.
Induction of Vascular GTP-Cyclohydrolase I and Endogenous Tetrahydrobiopterin Synthesis Protect Against Inflammation-Induced Endothelial Dysfunction in Human Atherosclerosis
Vascular tetrahydrobiopterin (BH4) is an essential cofactor of endothelial nitric oxide synthase (eNOS), and its deficiency induces "uncoupling" of this enzyme, which leads to production of superoxide (O 2 Ϫ ) instead of nitric oxide (NO). We hypothesized that BH4 synthesis is stimulated by inflammation, and this may serve as an endogenous defense mechanism of the vascular wall against systemic inflammation. To address this hypothesis, we performed 4 sequential studies. In Study 1, acute inflammation (induced by vaccination with Salmonella typhi vaccine) rapidly increased circulating BH4 in parallel with systemic inflammatory markers and impaired endothelial function in healthy individuals. In Study 2, we observed that a functional haplotype (X haplotype) in the GCH1 gene, encoding GTP-cyclohydrolase I, the rate-limiting enzyme in BH4 biosynthesis, was associated with endothelial dysfunction in subjects with increased background inflammation. In Study 3, we screened a large cohort of patients with coronary atherosclerosis and recruited patients on the basis of their GCH1 genotype to receive proinflammatory stimulation with S typhi vaccine. We observed that those with XX genotype were unable to increase plasma biopterins after vaccination, and these patients had a greater reduction of FMD than those with OO genotype. In Study 4, we used ex vivo models of human arteries and veins to demonstrate that the ability of these vessels to increase GCH1 gene expression and improve BH4 bioavailability in response to cytokine stimulation preserves vascular endothelial function. These novel findings suggest that vascular BH4 may constitute a novel therapeutic target for the treatment of endothelial dysfunction in inflammatory states such as human atherosclerosis. See p 1860.
Wnt Signaling Mediates Pathological Vascular Growth in Proliferative Retinopathy
Pathological neovascularization in ischemic proliferative retinopathies such as retinopathy of prematurity and diabetic retinopathy is a major cause of blindness in children and working-age adults. Although anti-vascular endothelial growth factor therapy has been proven partially successful in the suppression of neovascularization, identification of other signaling mechanisms involved in this disease process is essential for developing therapies specifically targeting pathological vessels while sparing normal vessels. Here, we found that the Wnt signaling pathway, a pathway important for cardiac development and differentiation, is a major component in regulating pathological neovascularization in retinopathy. Using a mouse model of oxygen-induced retinopathy, we found that Wnt ligands and receptors are highly upregulated in retinas with induced retinopathy and pathological neovessels, respectively. Mutant mice lacking Wnt coreceptor Lrp5 or downstream signaling molecule dishevelled2 have significantly decreased levels of neovascularization. Importantly, the proangiogenic effect of Wnt signaling is mediated through tight junction protein claudin5, which is highly downregulated in Lrp5-null vessels. Suppression of claudin5 significantly inhibits Wnt-mediated vascular growth in vitro and pathological vessel growth in vivo. Our data suggest that Wnt signaling pathway plays a significant role in mediating pathological vascular growth in ischemic proliferative retinopathy, and selectively targeting this pathway might be a potentially useful strategy to develop future therapies for retinopathy. See p 1871.
